Stago UK Ltd
Moulden Way
COMPANY INFORMATION
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote problem-solving. Customers also benefit from the additional features of our external and internal quality control systems, to monitor system performance and support UKAS accreditation.
Almost one quarter of NHS labs now rely on our robust, highly sensitive and specific assays, whilst automated algorithms aid in the diagnosis of complex disease, helping to rule out potentially costly and unnecessary procedures.
From high throughput instruments to more compact models, Stago is increasingly the provider of first choice for haematology labs. Whether in stand-alone or multi-site network configurations, our highly efficient, instruments have minimal hands-on requirement and align with ease to existing automated systems.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...
Lab Innovations
NEC, Birmingham
4-5 November, 2026
UK NEQAS webinar: IHC Applications in Laboratory Practice
Online
10-12 November, 2026
BAC Annual Scientific Meeting
Newcastle upon Tyne
13 November, 2026
DIA-MHRA Global Summit
Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026
POCT Innovators: Power to Disrupt - Clinical Diagnostics Now
Leonardo Royal Hotel, Oxford
16 November, 2025